Brasada Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$558K Buy
+1,542
New +$528K 0.1% 118
2024
Q2
Sell
-2,500
Closed -$711K 136
2024
Q1
$711K Buy
2,500
+500
+25% +$146K 0.13% 112
2023
Q4
$576K Buy
+2,000
New +$545K 0.11% 112
2019
Q1
Sell
-104
Closed -$20K 161
2018
Q4
$20K Sell
104
-24
-19% -$4.68K 0.01% 211
2018
Q3
$27K Sell
128
-422
-77% -$83.2K 0.01% 232
2018
Q2
$102K Hold
550
0.03% 183
2018
Q1
$93K Hold
550
0.03% 174
2017
Q4
$96K Buy
+550
New +$97.3K 0.03% 164

Other funds holding AMGN

Brasada Capital Management's AMGN Position: Q2 2026 in Review

Brasada Capital Management opened a new position in Amgen (AMGN) in Q2 2026: 1,542 shares worth $558K. The stake represents 0.1% of the portfolio and ranks #118 among its holdings. This is a return to the name: Brasada Capital Management previously reported a position in AMGN as recently as Q1 2024.

Brasada Capital Management first reported a position in AMGN in Q4 2017 and has held it in 8 quarters since. The position peaked at $711K in Q1 2024. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brasada Capital Management held 1,542 shares of Amgen worth $558K as of Q2 2026.
  • Amgen was a new Brasada Capital Management position in Q2 2026.
  • Amgen made up 0.1% of Brasada Capital Management's portfolio in Q2 2026, its #118 holding.
  • Brasada Capital Management first reported a position in Amgen in Q4 2017 and has held it in 8 quarters since.
  • Brasada Capital Management's Amgen position peaked at $711K in Q1 2024.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brasada Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.